BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ALR Technologies Inc. Releases Video Demonstrating the Value of the Health-e-Connect Remote Diabetes Management Program to Employers


3/18/2013 9:44:29 AM

RICHMOND, VA--(Marketwire - March 18, 2013) - ALR Technologies (OTCBB: ALRT) began the second phase of its commercial launch in the United States with the release of a detailed marketing video demonstrating the potential value to employers of improved diabetes care management including reduced healthcare costs, greater employee satisfaction and improved workplace safety. The presentation explains how remote monitoring and care coordination may improve the quality of employer-provided healthcare and assist employers in meeting key goals.

"Every survey of corporate human resources executives tells us that the management of chronic disease, and specifically, the management of diabetes, is critical in managing overall healthcare costs," said ALRT CEO Sidney Chan. "Our program will be a robust tool for employers because it combines remote monitoring, care coordination and communication with employees and clinicians in a way that can demonstrate measureable progress to employers on the chronic disease front," said Mr. Chan.

ALRT President Larry Weinstein added: "All employers are searching for ways to reduce health-care costs and to increase employee satisfaction and productivity. The economics of self-insured employers, in particular, heighten the importance of managing chronic diseases. With our Health-e-Connect Remote Diabetes Management Program, we are now in a position to assist employers with what may be their largest healthcare challenge: limiting the human toll and the financial costs inflicted by the chronic disease of diabetes."

The newly released video contains a detailed presentation on how the remote monitoring and care coordination process will work and why it will be valuable to employers. ALRT believes that self-insured employers, who directly pay the claims for their employees' healthcare, will have keen interest in a program that may help them manage the costs of diabetes. Last week, ALR Technologies announced a partnership with the Mid-America Coalition on Health Care, an employer-driven association representing some of the nation's largest employers and dedicated to improving the quality and lowering the costs of employer healthcare plans.

The video can be viewed here: http://www.youtube.com/watch?v=GbTTrQMni9k

About ALR Technologies Inc.

ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange.


Contact:
ALRT Sales and Marketing
Jerry Hickey
203.258.6327



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES